Plain-English translation of NCT06554717 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether , a medication already approved to treat belly fat in people with HIV, can help improve muscle strength and physical function when combined with exercise. People with HIV often experience weakness and reduced physical fitness earlier in life than others, and exercise alone doesn't always work as well as it does for people without HIV. This study will see if adding this medication to a supervised exercise program makes a real difference.
People with HIV tend to lose muscle strength and develop frailty earlier than the general population, and standard exercise programs don't always help as much as doctors would like. This medication has shown promise for building muscle, but researchers haven't yet tested whether it can actually improve how strong and physically capable people feel and perform.
You likely qualify if…
You likely don't qualify if…
You would participate in two phases over 48 weeks total. For the first 24 weeks, you would receive daily injections of either the medication or a placebo (inactive look-alike), and you would also follow a home-based exercise program supervised by a coach. After those 24 weeks, you would continue to be monitored for another 24 weeks without the study medication or formal supervision, though you'd be encouraged to keep exercising on your own. Throughout the trial, researchers will measure changes in your muscle strength, physical function, and quality of life.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States